TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Clinical Trial to Improve Colon Cancer Screening in Poor Rural Iowa Counties
Brief Summary: The goal of the study is to conduct a randomized clinical trial to test several office-based strategies for improving colon cancer screening among individuals who are regular patients at 16 family practice physician offices in the state of Iowa. These offices are members of the Iowa Research Network (IRENE), a rural practice-based research network. The interventions to be tested are increasing in intensity from the usual care provided in the office, to physician chart reminders, mailed educational materials to patients, a fecal immunochemical test with postage-paid return envelope, and a telephone call designed to determine attitudes and barriers to screening, and to motivate subjects to get screened. Our main research questions are: 1)do attitudes toward CRC screening change after providing educational materials about CRC screening? 2)do mailed educational materials and a FIT, with or without a telephone reminder, result in increased rates of CRC testing with the FIT?


Options:
A: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Educational Reminder | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Educational Reminder | Intervention Type: BEHAVIORAL; Name: Educational Reminder; Assigned to Arm(s): Control, Intervention
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: Reminders and opinion leader generated guidelines +/- leaflets and counselling | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: BEHAVIORAL; Name: Reminders and opinion leader generated guidelines +/- leaflets and counselling; Assigned to Arm(s): A | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): B
C: Arm Label: physician chart reminder; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physician chart reminder | Arm Label: chart reminder, educational mat'ls, FIT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physician chart reminder, Behavioral: chart reminder, educational mat'ls, FIT | Arm Label: CR, ed mat'ls, FIT, phone call; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physician chart reminder, Behavioral: CR,ed mat'ls, FIT, phone call | Intervention Type: BEHAVIORAL; Name: Physician chart reminder; Assigned to Arm(s): CR, ed mat'ls, FIT, phone call, chart reminder, educational mat'ls, FIT, physician chart reminder | Intervention Type: BEHAVIORAL; Name: chart reminder, educational mat'ls, FIT; Assigned to Arm(s): chart reminder, educational mat'ls, FIT | Intervention Type: BEHAVIORAL; Name: CR,ed mat'ls, FIT, phone call; Assigned to Arm(s): CR, ed mat'ls, FIT, phone call
D: Arm Label: reminders, no reminder; Type: EXPERIMENTAL; Interventions: Behavioral: reminders vs. no reminders | Intervention Type: BEHAVIORAL; Name: reminders vs. no reminders; Assigned to Arm(s): reminders, no reminder

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Medium Term Health Coaching and Life-long Monitoring in Cardiovascular Disease in Norrbotten
Brief Summary: The purpose of this study is to evaluate whether the introduction of large-scale personalized and technology supported telemonitoring and health coaching interventions produces benefits in terms of health related quality of life, health status and empowerment of patients with a cardiovascular disease. In addition, the trials evaluate the economical and organizational impact of the new services and examine their acceptability by patients and health professionals.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Toolkit | Arm Label: Control; Type: OTHER; Interventions: Other: Control | Intervention Type: OTHER; Name: Toolkit; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
B: Arm Label: Diabetes Educational Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Diabetes Education | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Diabetes Education; Assigned to Arm(s): Diabetes Educational Intervention
C: Intervention Type: BEHAVIORAL; Name: Resistance Training; Assigned to Arm(s): N/A
D: Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Health coaching and and Life-long Monitoring; Type: EXPERIMENTAL; Interventions: Procedure: Health Coaching and Life-long Monitoring | Intervention Type: PROCEDURE; Name: Health Coaching and Life-long Monitoring; Assigned to Arm(s): Health coaching and and Life-long Monitoring

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Contingency Management for Persons With Severe Mental Illness
Brief Summary: Contingency management is efficacious for treating cocaine abuse, but contingency management interventions have rarely been applied to patients with severe and persistent mental health problems. This pilot project will estimate effect sizes of contingency management for reducing cocaine use in patients receiving psychiatric care at a large community based mental health program. In total, 30 cocaine abusing patients will be randomized to one of two 8-week treatment conditions: standard care or standard care with contingency management. Patients in both conditions will provide breath and urine samples for toxicology testing twice per week. In the contingency management condition, patients will receive the opportunity to win prizes for submitting cocaine negative urine samples. The investigators expect that patients receiving contingency management will evidence reductions in cocaine use and may show improvements in psychiatric symptoms and psychosocial functioning relative to patients in standard care. Effect size estimates obtained from this study will be used to guide larger scale and longer duration evaluations of contingency management for dually diagnosed patients.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment as usual (TAU) | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: Treatment as usual (TAU), Behavioral: CBT for CBT | Intervention Type: OTHER; Name: Treatment as usual (TAU); Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: CBT for CBT; Assigned to Arm(s): 2
B: Arm Label: A Woman's Path to Recovery (WPR); Type: EXPERIMENTAL; Interventions: Behavioral: A Woman's Path to Recovery | Arm Label: 12-Step Facilitation (TSF); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 12-Step Facilitation | Intervention Type: BEHAVIORAL; Name: A Woman's Path to Recovery; Assigned to Arm(s): A Woman's Path to Recovery (WPR) | Intervention Type: BEHAVIORAL; Name: 12-Step Facilitation; Assigned to Arm(s): 12-Step Facilitation (TSF)
C: Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Treatment as usual + CBT4CBT; Type: EXPERIMENTAL; Interventions: Behavioral: CBT4CBT | Intervention Type: BEHAVIORAL; Name: CBT4CBT; Assigned to Arm(s): Treatment as usual + CBT4CBT
D: Arm Label: Standard Care; Type: PLACEBO_COMPARATOR; Interventions: Other: Standard Care | Arm Label: Contingency management for abstinence from drugs; Type: EXPERIMENTAL; Interventions: Behavioral: contingency management | Intervention Type: BEHAVIORAL; Name: contingency management; Assigned to Arm(s): Contingency management for abstinence from drugs | Intervention Type: OTHER; Name: Standard Care; Assigned to Arm(s): Standard Care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Contingency Management for Persons With Severe Mental Illness
Brief Summary: Contingency management is efficacious for treating cocaine abuse, but contingency management interventions have rarely been applied to patients with severe and persistent mental health problems. This pilot project will estimate effect sizes of contingency management for reducing cocaine use in patients receiving psychiatric care at a large community based mental health program. In total, 30 cocaine abusing patients will be randomized to one of two 8-week treatment conditions: standard care or standard care with contingency management. Patients in both conditions will provide breath and urine samples for toxicology testing twice per week. In the contingency management condition, patients will receive the opportunity to win prizes for submitting cocaine negative urine samples. The investigators expect that patients receiving contingency management will evidence reductions in cocaine use and may show improvements in psychiatric symptoms and psychosocial functioning relative to patients in standard care. Effect size estimates obtained from this study will be used to guide larger scale and longer duration evaluations of contingency management for dually diagnosed patients.


Options:
A: Arm Label: Standard Care; Type: PLACEBO_COMPARATOR; Interventions: Other: Standard Care | Arm Label: Contingency management for abstinence from drugs; Type: EXPERIMENTAL; Interventions: Behavioral: contingency management | Intervention Type: BEHAVIORAL; Name: contingency management; Assigned to Arm(s): Contingency management for abstinence from drugs | Intervention Type: OTHER; Name: Standard Care; Assigned to Arm(s): Standard Care
B: Intervention Type: BEHAVIORAL; Name: contingency management and behavioral day treatment; Assigned to Arm(s): N/A
C: Arm Label: Referral to community resources; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Contingency Management; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency management | Intervention Type: BEHAVIORAL; Name: Contingency management; Assigned to Arm(s): Contingency Management
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: 2; Type: OTHER; Interventions: Behavioral: Non Contingent Control Condition | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Non Contingent Control Condition; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Contingency Management for Persons With Severe Mental Illness
Brief Summary: Contingency management is efficacious for treating cocaine abuse, but contingency management interventions have rarely been applied to patients with severe and persistent mental health problems. This pilot project will estimate effect sizes of contingency management for reducing cocaine use in patients receiving psychiatric care at a large community based mental health program. In total, 30 cocaine abusing patients will be randomized to one of two 8-week treatment conditions: standard care or standard care with contingency management. Patients in both conditions will provide breath and urine samples for toxicology testing twice per week. In the contingency management condition, patients will receive the opportunity to win prizes for submitting cocaine negative urine samples. The investigators expect that patients receiving contingency management will evidence reductions in cocaine use and may show improvements in psychiatric symptoms and psychosocial functioning relative to patients in standard care. Effect size estimates obtained from this study will be used to guide larger scale and longer duration evaluations of contingency management for dually diagnosed patients.


Options:
A: Intervention Type: BEHAVIORAL; Name: Motivational Interview with care plan and education; Assigned to Arm(s): N/A
B: Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive-behavioral therapy program to first-episode psychosis patients and cannabis abuse | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychoeducation | Intervention Type: BEHAVIORAL; Name: Cognitive-behavioral therapy program to first-episode psychosis patients and cannabis abuse; Assigned to Arm(s): Experimental group | Intervention Type: BEHAVIORAL; Name: Psychoeducation; Assigned to Arm(s): Control group
C: Arm Label: Standard Care; Type: PLACEBO_COMPARATOR; Interventions: Other: Standard Care | Arm Label: Contingency management for abstinence from drugs; Type: EXPERIMENTAL; Interventions: Behavioral: contingency management | Intervention Type: BEHAVIORAL; Name: contingency management; Assigned to Arm(s): Contingency management for abstinence from drugs | Intervention Type: OTHER; Name: Standard Care; Assigned to Arm(s): Standard Care
D: Arm Label: CET/PT; Type: EXPERIMENTAL; Interventions: Behavioral: CET/PT | Arm Label: Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as Usual | Intervention Type: BEHAVIORAL; Name: CET/PT; Assigned to Arm(s): CET/PT | Intervention Type: BEHAVIORAL; Name: Treatment as Usual; Assigned to Arm(s): Treatment as Usual

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Bariatric Surgery in Swedish Obese Subjects
Brief Summary: The purpose of the Swedish Obese Subjects (SOS) study is to examine the long-term effects of bariatric surgery on overall mortality and obesity-related co-morbidities.


Options:
A: Arm Label: Bariatric surgery; Type: OTHER; Interventions: Procedure: Bariatric surgery | Arm Label: Controls; Type: OTHER; Interventions: Other: Usual care | Intervention Type: PROCEDURE; Name: Bariatric surgery; Assigned to Arm(s): Bariatric surgery | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Controls
B: Arm Label: gastric ring surgery; Type: EXPERIMENTAL; Interventions: Procedure: gastric ring surgery | Arm Label: nutritional help; Type: ACTIVE_COMPARATOR; Interventions: Other: nutritional help | Intervention Type: PROCEDURE; Name: gastric ring surgery; Assigned to Arm(s): gastric ring surgery | Intervention Type: OTHER; Name: nutritional help; Assigned to Arm(s): nutritional help
C: Arm Label: Bariatric surgery; Type: EXPERIMENTAL; Interventions: Procedure: Laparoscopic Roux-en-Y gastric bypass | Arm Label: Intense conservative treatment; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Intense conservative treatment | Intervention Type: PROCEDURE; Name: Laparoscopic Roux-en-Y gastric bypass; Assigned to Arm(s): Bariatric surgery | Intervention Type: PROCEDURE; Name: Intense conservative treatment; Assigned to Arm(s): Intense conservative treatment
D: N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of [Azilect®] Rasagiline in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China
Brief Summary: The rationale for conducting this study is to evaluate the efficacy, tolerability, and safety of rasagiline compared to placebo in levodopa-treated Parkinson's Disease (PD) Chinese patients with motor fluctuations. Azilect® (Rasagiline) is indicated for the treatment of idiopathic PD as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Azilect®; Type: EXPERIMENTAL; Interventions: Drug: Azilect® | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Azilect®; Assigned to Arm(s): Azilect®
B: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Other: interactive video game-based exercise, Other: no intervention | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Other: interactive video game-based exercise, Other: no intervention | Intervention Type: OTHER; Name: interactive video game-based exercise; Assigned to Arm(s): Group A, Group B | Intervention Type: OTHER; Name: no intervention; Assigned to Arm(s): Group A, Group B
C: Arm Label: Droxidopa; Type: EXPERIMENTAL; Interventions: Drug: Droxidopa | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Droxidopa; Assigned to Arm(s): Droxidopa | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Physical Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Therapy | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Physical Therapy; Assigned to Arm(s): Physical Therapy

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intra-abdominal at Cesarean Section: A Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine if intra-abdominal irrigation at the time of cesarean delivery increased maternal GI discomfort without affecting infection rates.

We hypothesized that avoiding intra-operative irrigation at the time of cesarean delivery will decrease intra-operative nausea and vomiting without increasing maternal infectious morbidity, post-operative pain, return of bowel function, or time to discharge.


Options:
A: Arm Label: Gentamicin lavage; Type: EXPERIMENTAL; Interventions: Drug: Axillary lavage with gentamicin solution | Arm Label: Normal saline lavage; Type: ACTIVE_COMPARATOR; Interventions: Drug: Axillary lavage with gentamicin solution | Intervention Type: DRUG; Name: Axillary lavage with gentamicin solution; Assigned to Arm(s): Gentamicin lavage, Normal saline lavage
B: Arm Label: SILS; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Single Incision Laparoscopic Appendectomy | Arm Label: 3 port; Type: ACTIVE_COMPARATOR; Interventions: Procedure: 3 port laparoscopic appendectomy | Intervention Type: PROCEDURE; Name: Single Incision Laparoscopic Appendectomy; Assigned to Arm(s): SILS | Intervention Type: PROCEDURE; Name: 3 port laparoscopic appendectomy; Assigned to Arm(s): 3 port
C: Arm Label: intraoperative colon lavage; Type: EXPERIMENTAL; Interventions: Procedure: intraoperative colon lavage with primary anastomosis | Arm Label: stent and deferred surgery; Type: ACTIVE_COMPARATOR; Interventions: Procedure: intraoperative colon lavage with primary anastomosis | Intervention Type: PROCEDURE; Name: intraoperative colon lavage with primary anastomosis; Assigned to Arm(s): intraoperative colon lavage, stent and deferred surgery
D: Arm Label: Irrigation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Normal Saline Irrigation | Arm Label: No Irrigation; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Normal Saline Irrigation; Assigned to Arm(s): Irrigation

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intra-abdominal at Cesarean Section: A Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine if intra-abdominal irrigation at the time of cesarean delivery increased maternal GI discomfort without affecting infection rates.

We hypothesized that avoiding intra-operative irrigation at the time of cesarean delivery will decrease intra-operative nausea and vomiting without increasing maternal infectious morbidity, post-operative pain, return of bowel function, or time to discharge.


Options:
A: Arm Label: Phenylephrine bolus; Type: EXPERIMENTAL; Interventions: Drug: Phenylephrine bolus | Arm Label: Phenylephrine infusion; Type: EXPERIMENTAL; Interventions: Drug: phenylephrine infusion | Intervention Type: DRUG; Name: Phenylephrine bolus; Assigned to Arm(s): Phenylephrine bolus | Intervention Type: DRUG; Name: phenylephrine infusion; Assigned to Arm(s): Phenylephrine infusion
B: Arm Label: Dexamethasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Dexamethasone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Ginger; Type: EXPERIMENTAL; Interventions: Drug: Ginger | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Oral Tablet | Intervention Type: DRUG; Name: Ginger; Assigned to Arm(s): Ginger | Intervention Type: DRUG; Name: Placebo Oral Tablet; Assigned to Arm(s): Placebo
D: Arm Label: Irrigation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Normal Saline Irrigation | Arm Label: No Irrigation; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Normal Saline Irrigation; Assigned to Arm(s): Irrigation

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Sugammadex Compared With Usual Care for Reversal of Neuromuscular Blockade Induced by Rocuronium on Incidence of Residual Blockade at PACU Entry
Brief Summary: This study will compare the incidence of residual neuromuscular blockade in participants who undergo reversal of neuromuscular blockade with sugammadex compared to those who undergo reversal of neuromuscular blockade with usual care (neostigmine/glycopyrrolate).


Options:
A: Arm Label: Sugammadex; Type: EXPERIMENTAL; Interventions: Drug: Sugammadex | Arm Label: Neostigmine/glycopyrrolate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Neostigmine, Drug: Glycopyrrolate | Intervention Type: DRUG; Name: Sugammadex; Assigned to Arm(s): Sugammadex | Intervention Type: DRUG; Name: Neostigmine; Assigned to Arm(s): Neostigmine/glycopyrrolate | Intervention Type: DRUG; Name: Glycopyrrolate; Assigned to Arm(s): Neostigmine/glycopyrrolate
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: donepezil | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: donepezil; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Bispectral index protocol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: End tidal anesthetic gas-guided | Intervention Type: BEHAVIORAL; Name: Bispectral index protocol; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: End tidal anesthetic gas-guided; Assigned to Arm(s): 2
D: Arm Label: Investigational medicinal product; Type: ACTIVE_COMPARATOR; Interventions: Drug: Haloperidol | Arm Label: Placebo group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Haloperidol; Assigned to Arm(s): Investigational medicinal product | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo group

Answer: A